Page last updated: 2024-12-06
topsentin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
topsentin: structure given in first source; a marine natural product [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 72457 |
CHEMBL ID | 303282 |
SCHEMBL ID | 19235593 |
MeSH ID | M0191245 |
Synonyms (15)
Synonym |
---|
topsentine b 1 |
methanone, (6-hydroxy-1h-indol-3-yl)(4-(1h-indol-3-yl)-1h-imidazol-2-yl)- |
112515-43-2 |
topsentin |
(6-hydroxy-1h-indol-3-yl)-[4-(1h-indol-3-yl)-1h-imidazol-2-yl]methanone |
6-hydroxy-3-[(4-indol-3-ylimidazol-2-yl)carbonyl]indole |
topsentin b1 |
CHEMBL303282 , |
(6-hydroxy-1h-indol-3-yl)-[5-(1h-indol-3-yl)-1h-imidazol-2-yl]methanone |
TVPNFKRGOFJQOO-UHFFFAOYSA-N |
bdbm50287721 |
(6-hydroxy-1h-indol-3-yl)-[5-(1h-indol-3-yl)-1h-imidazol-2-yl]-methanone |
methanone,(6-hydroxy-1h-indol-3-yl)[5-(1h-indol-3-yl)-1h-imidazol-2-yl]- |
DTXSID30150087 |
SCHEMBL19235593 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (8)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1435526 | Cytotoxicity against human HeLa cells after 72 hrs by MTT assay | 2016 | Journal of natural products, 11-23, Volume: 79, Issue:11 | Dragmacidins G and H, Bisindole Alkaloids Tethered by a Guanidino Ethylthiopyrazine Moiety, from a Lipastrotethya sp. Marine Sponge. |
AID401681 | Cytotoxicity against human XF498 cells after 48 hrs by SRB assay | 2005 | Journal of natural products, May, Volume: 68, Issue:5 | Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp. |
AID379675 | Cytotoxicity against human NSCLC-N6 cells by colorimetric assay | 2000 | Journal of natural products, Apr, Volume: 63, Issue:4 | New bisindole alkaloids of the topsentin and hamacanthin classes from the Mediterranean marine sponge Rhaphisia lacazei. |
AID401678 | Cytotoxicity against human A549 cells after 48 hrs by SRB assay | 2005 | Journal of natural products, May, Volume: 68, Issue:5 | Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp. |
AID401692 | Cytotoxicity against mouse P388 cells | 2005 | Journal of natural products, May, Volume: 68, Issue:5 | Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp. |
AID401682 | Cytotoxicity against human HCT15 cells after 48 hrs by SRB assay | 2005 | Journal of natural products, May, Volume: 68, Issue:5 | Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp. |
AID401679 | Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay | 2005 | Journal of natural products, May, Volume: 68, Issue:5 | Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp. |
AID401680 | Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay | 2005 | Journal of natural products, May, Volume: 68, Issue:5 | Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 3 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 22.68
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.68) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |